One in eight women develop breast cancer in their lifetime. Of those women, 15–20% are diagnosed with triple negative breast cancer (TNBC), an aggressive form of breast cancer. The incidence rate of TNBC in African-American women is close to double other ethnic groups. Dr. Heather Dunn, in the Department of Animal and Veterinary Sciences, mentors the Bioinformatics for Cancer Genomics Creative Inquiry project. The project’s goal is to investigate early mammary gland development because certain types of aggressive human breast cancers including TNBC potentially reactivate the developmental cellular processes. In addition, these aggressive types of breast cancer lack Food and Drug Administration approved drugs so patients diagnosed with TNBC are prescribed a treatment regime for other cancer profiles. Sometimes the patients respond to these treatments, but it is far from ideal.